Pascal Chanez
Impact in
- Physiology top 0.01%
- Asthma and respiratory diseases
- Immunology and Allergy top 0.2%
- Allergic Rhinitis and Sensitization
Papers in
- Physiology 371
- Asthma and respiratory diseases 365
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 66
- Cystic Fibrosis Research Advances 7
- Co-authors
- Jean Bousquet (133 shared papers)Philippe Godard (129 shared papers)François Bernard Michel (62 shared papers)Ian Douglas Pavord (9 shared papers)Isabelle Vachier (84 shared papers)Hector G. Ortega (3 shared papers)Oliver N. Keene (4 shared papers)Antonio Maurizio Vignola (43 shared papers)
- Journals
- European Respiratory Journal (60 papers)Journal of Allergy and Clinical Immunology (50 papers)Allergy (34 papers)American Journal of Respiratory and Critical Care Medicine (29 papers)European Respiratory Review (23 papers)
- Partner nations
- FranceUnited KingdomItaly
In The Last Decade
Pascal Chanez
494 papers receiving 36.7k citations
Pascal Chanez's Hit Papers
Peers
Comparison fields: 5 of 174
- Physiology 25.9k
- Immunology and Allergy 1.7k
- Pulmonary and Respiratory Medicine 6.5k
- Otorhinolaryngology 871
- Family Practice 220
Countries citing papers authored by Pascal Chanez
This map shows the geographic impact of Pascal Chanez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Chanez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Chanez more than expected).
Fields of papers citing papers by Pascal Chanez
This network shows the impact of papers produced by Pascal Chanez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Chanez. The network helps show where Pascal Chanez may publish in the future.
Co-authors
The 25 scholars most cited alongside Pascal Chanez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 514 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma Hit paper breakdown → | 2013 | 3171 |
| 2 | Eosinophilic Inflammation in Asthma Hit paper breakdown → | 1990 | 2198 |
| 3 | Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma Hit paper breakdown → | 2014 | 1898 |
| 4 | Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial Hit paper breakdown → | 2012 | 1862 |
| 5 | An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations Hit paper breakdown → | 2009 | 1622 |
| 6 | Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial Hit paper breakdown → | 2016 | 1157 |
| 7 | Induction of nitric oxide synthase in asthma Hit paper breakdown → | 1993 | 728 |
| 8 | 1997 | 514 | |
| 9 | Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease Hit paper breakdown → | 2017 | 506 |
| 10 | Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline Hit paper breakdown → | 2019 | 501 |
| 11 | Farm dust and endotoxin protect against allergy through A20 induction in lung epithelial cells Hit paper breakdown → | 2015 | 493 |
| 12 | Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD Hit paper breakdown → | 2014 | 489 |
| 13 | Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort Hit paper breakdown → | 2015 | 474 |
| 14 | 2009 | 403 | |
| 15 | 2008 | 369 | |
| 16 | Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial Hit paper breakdown → | 2016 | 349 |
| 17 | 1998 | 345 | |
| 18 | 2015 | 320 | |
| 19 | 1993 | 319 | |
| 20 | 2008 | 301 |
About Pascal Chanez
Pascal Chanez is a scholar working on Physiology, Pulmonary and Respiratory Medicine, Immunology and Allergy, Biochemistry and Immunology, having authored 514 papers that have together received 38.4k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (365 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (66 papers), Allergic Rhinitis and Sensitization (14 papers), Eicosanoids and Hypertension Pharmacology (8 papers), Medication Adherence and Compliance (7 papers), Mast cells and histamine (7 papers), Cystic Fibrosis Research Advances (7 papers) and Fatty Acid Research and Health (7 papers). The work is most often cited by research in Physiology (25.9k citations), Immunology and Allergy (1.7k citations), Pulmonary and Respiratory Medicine (6.5k citations), Otorhinolaryngology (871 citations) and Family Practice (220 citations). Pascal Chanez has collaborated with scholars based in France, United Kingdom and Italy. Frequent co-authors include Jean Bousquet, Philippe Godard, François Bernard Michel, Ian Douglas Pavord, Isabelle Vachier, Hector G. Ortega, Oliver N. Keene, Antonio Maurizio Vignola, Eugene R. Bleecker and Ingrid Enander. Their work appears in journals such as European Respiratory Journal, Journal of Allergy and Clinical Immunology, Allergy, American Journal of Respiratory and Critical Care Medicine and European Respiratory Review.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.